STEREOSELECTIVE DISPOSITION OF IBUPROFEN ENANTIOMERS IN HUMAN CEREBROSPINAL-FLUID

被引:53
作者
BANNWARTH, B
LAPICQUE, F
PEHOURCQ, F
GILLET, P
SCHAEVERBEKE, T
LABORDE, C
DEHAIS, J
GAUCHER, A
NETTER, P
机构
[1] UNIV BORDEAUX 2,HOP PELLEGRIN,DEPT CLIN PHARMACOL,F-33076 BORDEAUX,FRANCE
[2] CHU NANCY BRABOIS,FAC MED,DEPT PHARMACOL,CNRS,URA 1288,NANCY,FRANCE
[3] CHU NANCY BRABOIS,FAC MED,DEPT RHEUMATOL,CNRS,URA 1288,NANCY,FRANCE
[4] UNIV BORDEAUX 2,HOP PELLEGRIN,DEPT RHEUMATOL,EA 525,BORDEAUX,FRANCE
[5] BOOTS PHARMA,DEPT CLIN RES,COURBEVOIE,FRANCE
关键词
IBUPROFEN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PLASMA AND CSF CONCENTRATIONS; CENTRAL NERVOUS SYSTEM;
D O I
10.1111/j.1365-2125.1995.tb05783.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Since both (R)- and (S)-enantiomers of ibuprofen may act on the central nervous system, we investigated their plasma and cerebrospinal fluid (CSF) concentrations in 46 patients with nerve-root compression pain requiring a lumbar puncture. Each patient received an oral dose of 800 mg rac-ibuprofen. A single blood and CSF sample was drawn concomitantly from each patient at intervals between 30 min and 8 h after dosing. Both isomers peaked later in the CSF (3 h) than in the plasma (1.5 h). Their CSF concentrations became higher than their concurrent free plasma concentrations after 90 min. The estimated elimination half-lives of (R)- and (S)-ibuprofen were 1.7 h and 2.5 h in plasma and 3.9 h and 7.9 h in CSF, respectively. The AUC(CSF)/AUC(plasma) ratios (0, 8 h) were 0.009 and 0.015 for the (R)- and (S)-forms, respectively.
引用
收藏
页码:266 / 269
页数:4
相关论文
共 14 条
  • [1] PLASMA AND CEREBROSPINAL-FLUID CONCENTRATIONS OF PARACETAMOL AFTER A SINGLE INTRAVENOUS DOSE OF PROPACETAMOL
    BANNWARTH, B
    NETTER, P
    LAPICQUE, F
    GILLET, P
    PERE, P
    BOCCARD, E
    ROYER, RJ
    GAUCHER, A
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (01) : 79 - 81
  • [2] PLASMA AND CEREBROSPINAL-FLUID CONCENTRATIONS OF INDOMETHACIN IN HUMANS - RELATIONSHIP TO ANALGESIC ACTIVITY
    BANNWARTH, B
    NETTER, P
    LAPICQUE, F
    PERE, P
    THOMAS, P
    GAUCHER, A
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (04) : 343 - 346
  • [3] WHERE ARE PERIPHERAL ANALGESICS ACTING
    BANNWARTH, B
    DEMOTESMAINARD, F
    SCHAEVERBEKE, T
    DEHAIS, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1993, 52 (01) : 1 - 4
  • [4] CLINICAL PHARMACOKINETICS OF CEREBROSPINAL-FLUID
    BONATI, M
    KANTO, J
    TOGNONI, G
    [J]. CLINICAL PHARMACOKINETICS, 1982, 7 (04) : 312 - 335
  • [5] EVANS AM, 1992, EUR J CLIN PHARMACOL, V42, P237
  • [6] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY OF KETOPROFEN ENANTIOMERS IN HUMAN-PLASMA AND URINE
    FOSTER, RT
    JAMALI, F
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 416 (02): : 388 - 393
  • [7] CENTRAL-NERVOUS-SYSTEM SIDE-EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS - ASEPTIC-MENINGITIS, PSYCHOSIS, AND COGNITIVE DYSFUNCTION
    HOPPMANN, RA
    PEDEN, JG
    OBER, SK
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (07) : 1309 - 1313
  • [8] PHARMACOKINETICS AND PHARMACODYNAMICS OF IBUPROFEN ISOMERS AND ACETAMINOPHEN IN FEBRILE CHILDREN
    KELLEY, MT
    WALSON, PD
    EDGE, JH
    COX, S
    MORTENSEN, ME
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (02) : 181 - 189
  • [9] LEE EJD, 1985, BRIT J CLIN PHARMACO, V19, P669, DOI 10.1111/j.1365-2125.1985.tb02694.x
  • [10] MALMBERG AB, 1992, J PHARMACOL EXP THER, V263, P136